Avience Biomedicals Ltd IPO

Avience Biomedicals Ltd IPO

Healthcare

sme

Bidding period

18 Jun 2026 - 22 Jun 2026

Bid price

₹196.00 - ₹208.00

Listing on

NSE-SME

Listing date

25 Jun 2026

Lot size

600 shares

Issue size

To be announced


Minimum investment

₹2,49,600.00 / 2 lot

Maximum investment

₹2,49,600.00 / 2 lot

Bidding closes in 6 days

Open Demat Account
Open Demat Account

Avience Biomedicals Ltd IPO dates

IPO opening date

18 Jun 2026

IPO end date

22 Jun 2026

Allotment date

23 Jun 2026

Initiation of refunds

24 Jun 2026

Credit of shares to demat

24 Jun 2026

IPO listing date

25 Jun 2026

Avience Biomedicals Ltd IPO financials

Particulars

For the period ending in March 2025 (in ₹ million)

Total assets ₹56.49
Total liabilities ₹56.49
Total expenditure ₹36.06
Total revenue ₹45.91
Profit after tax ₹7.10
EBITDA ₹12.07
Adjusted EBITDA ₹0.00

Avience Biomedicals Ltd shareholder pattern

Pre-issue Post-issue
Promoter group 0.0 0.0
Public group 100.0 100.0

Avience Biomedicals Ltd strengths and risks

Information currently unavailable

  • Experienced Management Team and trained Employees.

  • Optimal Utilization of Resources.

  • Quality assurance and control.

  • Cordial relationships with our clients.

  • The pharmaceutical market is subject to extensive regulation and failures to comply with the existing and future regulatory requirements in any pharmaceutical market could expose the company to litigation or other liabilities, which could adversely affect its reputation, business, financial condition and results of operations.

  • The company is dependent on certain customers for a portion of its revenues. The loss of any of the company's major customers due to any adverse development or significant reduction in business from the company's major customers may adversely affect its business, financial condition, results of operations and future prospects.

  • The company relies on suppliers for medical devices and equipment manufacturers for its trading goods, and also face risks in sourcing raw materials and components from third parties for the manufacturing and assembly of the company's medical equipment. Any disruption in the supply of these goods or materials could adversely impact its business, operations, and financial condition.

  • The company's Financial Statement as Restated are prepared and signed by the Peer Review Auditor who is not Statutory Auditors of the Company as required under the provisions of ICDR.

  • The purchase and sale of medical devices and equipment for the company's trading activities are heavily dependent on related parties.

  • Customer orders may experience delays, modifications, cancellations, or may not be fully paid, which could negatively impact its business, financial condition, and operational results.

  • The company requires sizeable amounts of working capital for its continued operation and growth. The company's inability to meet its working capital requirements could have a material adverse effect on the company's business, results of operations and financial condition.

  • Quality problems and product liability claims could lead to recalls or safety alerts, reputational harm, adverse verdicts or costly settlements, and could have an adverse effect on its business, results of operations, financial condition and cash flows.

  • The company's business is dependent on its manufacturing facilities and assembly units. Obsolescence, destruction, theft, breakdowns of the company's machineries or failures to repair or maintain the same may affect its business, cash flows, financial condition and results of operations.

  • The company relies on limited suppliers for its products, loss of these suppliers may have an adverse effect on the company's business, results of operations and financial conditions.

Avience Biomedicals Ltd IPO registrar

Skyline Financial Services Pvt

Phone number 011-40450193-197
E-mail ID grievances@skylinerta.com
Website www.skylinerta.com

Avience Biomedicals Ltd IPO reservation

QIB shares offered

2,73,600 (18.82%)

NII (HNI) shares offered

2,07,000 (14.24%)

Retail shares offered

4,81,200 (33.1%)

Anchor investor shares offered

4,09,800 (28.19%)

Total shares offered

14,53,800

Total shares with anchor investor

14,53,800

Avience Biomedicals Ltd IPO lead manager

  • Fintellectual Corporate Advisors Pvt Ltd

Explore other IPOs

Advit Jewels Limited logo
Advit Jewels Limited logo

Advit Jewels Limited IPO

Bidding period

23 Jun 2026 - 25 Jun 2026

Bid price range

₹130.00 - ₹138.00
Aarvee Engineering Consultants Limited logo
Aarvee Engineering Consultants Limited logo

Aarvee Engineering Consultants Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Aastha Spintex Limited logo
Aastha Spintex Limited logo

Aastha Spintex Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Absolute Project India Limited logo
Absolute Project India Limited logo

Absolute Project India Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
AceVector Limited logo
AceVector Limited logo

AceVector Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
AceVector Limited logo
AceVector Limited logo

AceVector Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Adroit Industries India Limited logo
Adroit Industries India Limited logo

Adroit Industries India Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Advanced SysTek Limited logo
Advanced SysTek Limited logo

Advanced SysTek Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Advanta Enterprises Limited logo
Advanta Enterprises Limited logo

Advanta Enterprises Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Aggcon Equipments International Limited logo
Aggcon Equipments International Limited logo

Aggcon Equipments International Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Agilus Diagnostics Limited logo
Agilus Diagnostics Limited logo

Agilus Diagnostics Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Airox Technologies Limited logo
Airox Technologies Limited logo

Airox Technologies Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Ajay Poly Limited logo
Ajay Poly Limited logo

Ajay Poly Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Alcobrew Distilleries India Limited logo
Alcobrew Distilleries India Limited logo

Alcobrew Distilleries India Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Allchem Lifescience Limited logo
Allchem Lifescience Limited logo

Allchem Lifescience Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Allied Engineering Works Limited logo
Allied Engineering Works Limited logo

Allied Engineering Works Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced
Alpine Texworld Limited logo
Alpine Texworld Limited logo

Alpine Texworld Limited IPO

Bidding period

To Be Announced

Bid price range

To Be Announced

How to apply for an IPO with Bajaj Broking?

adafafds
 
 
  • Log in to the Bajaj Broking trading platform and select ‘IPO’ from the menu.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen IPO.
  • Enter the quantity and your UPI ID.
  • Submit your application—and you're done!

Frequently asked questions

What is the listing date for the Avience Biomedicals Ltd IPO?

The listing date for the Avience Biomedicals Ltd IPO is 25 Jun 2026.

What is the issue size of Avience Biomedicals Ltd IPO?

The issue size of the Avience Biomedicals Ltd IPO is unknown cr.

What is the minimum lot size needed for Avience Biomedicals Ltd IPO?

The minimum lot size for Avience Biomedicals Ltd IPO is 600

When does the Avience Biomedicals Ltd open and close?

Avience Biomedicals Ltd IPO is open from 18 Jun 2026 to 22 Jun 2026.

How can I apply for the Avience Biomedicals Ltd IPO?

To apply for the Avience Biomedicals Ltd, follow the steps given below:

  • Log in to your Bajaj Broking trading account and navigate to the current IPOs section.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen PO.
  • Enter the quantity and your UPI ID. You will receive a mandate notification to block funds in your UPI app.
SHOW MORE SHOW LESS

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines.
Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.

Powered by Bajaj Financial Securities Limited (Bajaj Broking)